Pestalachlorides A3a, A3b and pestalotinone E: three new compounds derivative from endolichenic fungi Pestalotiopsis rhododendri
This study reports the isolation and structural characterization of three new compounds, pestalachlorides A3a/A3b and pestalotinone E, along with the known analogue SB87-H, from the endolichenic fungus *Pestalotiopsis rhododendri*, highlighting the significant antibacterial activities of compounds 2 and 3 against various bacterial strains and proposing a plausible biosynthetic pathway for these metabolites.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Deep within the microscopic world of lichens, a complex partnership between fungi and algae creates a hidden laboratory for chemical innovation. Lichens are not single plants but living communities, and tucked inside their tissues reside endolichenic fungi. These microscopic residents are masters of survival, producing a vast array of natural chemicals to help their host withstand harsh environmental stresses. While scientists have identified thousands of these fungal species, only a tiny fraction have been chemically studied. This vast, unexplored territory holds the promise of discovering new molecules with powerful biological effects, particularly those capable of fighting infections that resist modern medicine. Among the most intriguing of these chemical families are benzophenones, a class of compounds known for their ability to attack drug-resistant bacteria and fungi.
Researchers at the Institute of Medicinal Biotechnology in Beijing turned their attention to a specific endolichenic fungus named Pestalotiopsis rhododendri, which they had previously identified as a promising source of new chemicals. By growing this fungus in large quantities in the lab, the team was able to harvest its chemical output and separate out individual compounds. From this process, they isolated four distinct substances. Three of these were entirely new to science: a pair of mirror-image molecules called pestalachlorides A3a and A3b, and a third compound named pestalotinone E. The fourth substance was a known chemical called SB87-H, which had been identified before but was found here again in this specific fungal strain.
The team spent considerable time mapping the exact structure of these new molecules using advanced spectroscopic tools, which act like a high-resolution camera for atoms, revealing how every piece fits together. They discovered that the new compounds shared a core framework with previously known chemicals but featured unique modifications. The pestalachlorides, for instance, contained two chlorine atoms and a specific arrangement of rings that made them mirror images of each other, a property that can significantly change how a molecule behaves in the body. The third new compound, pestalotinone E, possessed a distinctive oxygen bridge connecting different parts of its structure, a feature that distinguished it from its known relatives.
With the structures confirmed, the researchers tested how these chemicals interacted with dangerous bacteria. They exposed the compounds to a panel of clinically relevant strains, including those that are resistant to common antibiotics like methicillin. The results showed a clear difference in power between the new molecules. The known compound, SB87-H, proved to be the most effective, displaying strong activity against several types of resistant bacteria, including methicillin-resistant Staphylococcus aureus and a strain of Mycobacterium phlei. It was able to stop the growth of these bacteria at very low concentrations. Pestalotinone E also showed promise, particularly against Enterococcus faecium, though its activity was generally weaker than that of the known compound. Surprisingly, the two new mirror-image pestalachlorides showed no ability to inhibit the bacteria tested.
The study also looked at how these chemicals might be made by the fungus itself. By analyzing the genetic instructions within the fungus and comparing them to known biological pathways, the researchers proposed a likely route for how the fungus builds these complex molecules. They suggested that the process begins with a basic chemical assembly that is then modified by specific enzymes, some of which add chlorine atoms and others that rearrange the structure. This proposed pathway helps explain how the fungus generates such a diverse set of chemicals from a single starting point.
Ultimately, this work highlights the chemical richness hidden inside lichens. It confirms that even within a single fungal strain, nature can produce a variety of complex structures, some of which hold significant potential as tools against drug-resistant infections. While the new mirror-image compounds did not show antibacterial power in this specific test, the strong performance of the known compound and the moderate activity of the new pestalotinone suggest that this family of chemicals remains a valuable resource. The findings provide a clearer map of how these molecules are built and offer a foundation for future efforts to understand and potentially improve these natural defenses against bacterial disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.